From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome

Allergologia et Immunopathologia

Volumn 37, Issue 4, 2009, Pages 208-215

  Blanco Quiros A ^a   Arranz Sanz, E ^a   Bernardo Ordiz, D ^a   Garrote Adrados, J A ^a,b  

^a Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Autoimmune enteropathy; FOXP3 molecule; IPEX syndrome; Regulatory T cells

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CYCLOSPORIN; INFLIXIMAB; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; METHOTREXATE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ANEMIA; ANTIGEN EXPRESSION; AUTOIMMUNITY; BLEEDING DISORDER; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; DERMATITIS; DIARRHEA; ECZEMA; ENDOCRINE DISEASE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL DISEASE; GENE MUTATION; GENETIC VARIABILITY; HEMOPHAGOCYTIC SYNDROME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; MALNUTRITION; NONHUMAN; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; SHORT SURVEY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; X CHROMOSOME;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; HUMANS; INTESTINAL DISEASES; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE; SYNDROME; T-LYMPHOCYTES, REGULATORY;

EID: 70349747028     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2009.04.002     Document Type: Short Survey

References (61)

1. Avery G.B., Villacivencio O., Lilly J.R., and Randolph J.G. Intractable diarrhea of early infancy. Pediatrics 41 (1968) 712-722
2. Vanderhoof J.A., and Young R.J. Autoimmune enteropathy in a child: Response to Infliximab Therapy. J Pediatr Gastroenterol Nutr 34 (2002) 312-316
3. Walker-Smith J.A., Unsworth D.J., Hutchins P., Hutchins P., Phillips A.D., and Holborow E.J. Autoantibodies against gut epithelium in a child with small-intestinal enteropathy. Lancet 1 (1982) 566-567
4. Unsworth D.J., and Walker-Smith J.A. Autoimmune in diarrhoeal disease. J Pediatr Gastroenterol Nutr 4 (1985) 375-380
5. Savage M.O., Mirakian R., Wozniak E.R., Jenkins H.R., Malone M., Phillips A.D., et al. Specific autoantibodies to gut epithelium in two infants with severe protracted diarrhea. J Pediatr Gastroenterol Nutr 4 (1985) 187-195
6. Corazza G.R., Biagi F., Volta U., Andreani M.L., de Franceschi L., and Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet 350 (1997) 106-109
7. El-Matary W., Dalzell A.M., Kokai G., and Davidson J.E. Tuftin enteropathy and skeletal dysplasia: is there a link?. Eur J Pediatr 166 (2007) 265-268
8. Colletti R.B., Guillot A.P., Rosen S., Bhan A.K., Hobson C.D., Collins A.B., et al. Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. J Pediatr 118 (1991) 858-864
9. Martin Villa J.M., Regueiro J.R., de Juan D., Perez Aciego P., Pérez Blas M., Manzanares J., et al. T-Lymphocyte dysfunctions occurring together with apical gut epithelial cell autoantibodies. Gastroenterology 101 (1991) 390-397
10. Kobayashi I., Imamura K., Yamada M., Okano M., Yara A., Ikema S., et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin Exp Immunol 111 (1998) 527-531
11. Enkwall O., Hedstrand H., Grimelius L., Haavik J., Perheentupa J., Gustafsson J., et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352 (1998) 279-283
12. Lachaux A., Loras-Duclaux I., and Bouvier R. Autoimmune enteropathy in infants. Pathological study of the disease in two familial cases. Virchows Arch 433 (1998) 481-485
13. Hill S.M., Milla P.J., Bottazzo G.F., and Mirakian R. Autoimmune enteropathy and colitis: is there a generalised autoimmune gut disorder?. Gut 32 (1991) 36-42
14. Russo P.A., Brochu P., Seidman E.G., and Roy C.C. Autoimmune enteropathy. Pediatr Dev Pathol 2 (1999) 65-71
15. Powell B.R., Ruist N.R., and Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy and fatal infection in infancy. J Pediatr 100 (1982) 731-737
16. Godfrey V., Wilkinson J., and Russell L. X-linked lymphorreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 138 (1991) 1379-1387
17. Bennett C.L., and Ochs H.D. IPEX is a unique X-linked syndrome characterized by immune disfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 13 (2001) 533-538
18. Marabelle A., Meyer M., Demeocq F., and Lachaux A. De l'Ipex à foxp3: une nouvelle contribution de la pédiatrie à la comprehension du systeme immunitaire. Arch Pediatr 15 (2008) 55-63
19. Torgerson T.R., Linane A., Moes N., Anover S., Mateo V., Rieux-Laucat F., et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132 (2007) 1705-1717
20. McGinness J.L., Bivens M.M., Greer K.E., Patterson J.W., and Saulsbury F.T. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 55 (2006) 143-148
21. McLucas P., Fulchiero Jr. G.J., Fernandez E., Miller J.J., and Zaenglein A.L. Norwegian scabies mimicking onychomycosis and scalp dermatitis in a child with IPEX syndrome. J Am Acad Dermatol 56 (2007) S48-S49
22. Moudgil A., Perriello P., Loechelt B., Przygodzki R., Fitzerald W., and Kamani N. Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy. Pediatr Nephrol 22 (2007) 1799-1802
23. De Benedetti F., Insalaco A., Diamanti A., Cortis E., Muratori F., Lamioni A., et al. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome. Clin Gastroenterol Hepatol 4 (2006) 653-659
24. Heltzer M.L., Choi J.K., Ochs H.D., Sullivan K.E., Torgerson T.R., and Ernst L.M. A potential screening tool for IPEX syndrome. Pediatr Dev Pathol 10 (2007) 98-105
25. Vliet H.J.J.v.d., and Nieuwenhuis E.E. IPEX as a result of mutations in FOXP3. Clin Dev Immunol (2007) 10.1155/2007/89017
26. Zuber J., Viguier M., Lemaitre F., Senée V., Patey N., Elain G., et al. Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. Gastroenterology 132 (2007) 1694-1704
27. Costa-Carvalho B.T., de Moraes-Pinto M.I., de Almeida L.C., de Seixas Alves M.T., Maia R.P., de Souza R.L., et al. A remarkable depletion of both naïve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain. Scand J Immunol 68 (2008) 85-91
28. Torgerson T.R., and Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 120 (2007) 744-750
29. Bettelli E., Dastrange M., and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expresión and effector functions of T helper cells. Proc Natl Acad Sci U S A 102 (2005) 5138-5143
30. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
31. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 (2007) 685-689
32. Li B., Samanta A., Song X., Iacono K.T., Brennan P., Chatila T.A., et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol 19 (2007) 825-835
33. Lopes J.E., Torgerson T.R., Schubert L.A., Anover S.D., Ocheltree E.L., Ochs H.D., et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 177 (2006) 3133-3142
34. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 6 (2005) 331-337
35. Nik Tavakoli N, Hambly BD, Sullivan DR, Bao S. Forkhead box protein 3: Essential immune regulatory role. Int J Biochem Cell Biol. 2007 Oct 10 [Epub ahead of print]
36. Stock P., DeKruyff R.H., and Umetsu D.T. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol 6 (2006) 12-16
37. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., et al. Relation of CD4 CD25 regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 63 (2004) 608-615
38. Dubois B., Chapat L., Goubier A., Papiernik M., Nicolas J.F., and Kaiserlian D. Innate CD4 CD25 regulatory T cells are required for oral tolerance and inhibition of CD8T cells mediating skin inflammation. Blood 102 (2003) 3295-3301
39. Hauet-Broere F., Unger W.W., Garssen J., Hoijer M.A., Kraal G., and Samsom J.N. Functional CD25- and CD25 mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol 33 (2003) 2801-2810
40. Zhang X., Izikson L., Liu L., and Weiner H.L. Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J Immunol 167 (2001) 4245-4253
41. Bacchetta R., Gambineri E., and Roncarolo M.-G. Role of regulatory T cells and FOXP3 in human disease. J Allergy Clin Immunol 120 (2007) 227-235
42. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 36 (2006) 1357-1366
43. Karube K., Ohshima K., Tsuchiya T., Yamaguchi T., Kawano R., Suzumiya J., et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol 126 (2004) 81-84
44. Viguier M., Lemaitre F., Verola O., Cho M.S., Gorochov G., Dubertret L., et al. Foxp3 expressing CD4 CD25 (high) regulatory T cells are overrep-resented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173 (2004) 1444-1453
45. Berger C.L., Tigelaar R., Cohen J., Mariwalla K., Trinh J., Wang N., et al. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105 (2005) 1640-1647
46. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., and Ko-rangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65 (2005) 2457-2464
47. Wildin R.S., Smyk-Pearson S., and Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyen-docrinopathy, enteropathy, X linked (IPEX) síndrome. J Med Genet 39 (2002) 537-545
48. Owen C.J., Jennings C.E., Imrie H., Lachaux A., Bridges N.A., and Cheetham T.D. Mutational análisis of the FOXP 3 gene and evidence for genetic hetero-geneity in the immunodysregulation, polyendocrinopathy, en-teropathy syndrome. J Clin Endocrinol Metabol 88 (2003) 6034-6039
49. Le Bras S., and Geha R.S. IPEX and the role of FOXP 3 in the development and function of human Tregs. J Clin Invest 116 (2006) 1473-1475
50. Fuchizawa T., Adachi Y., Ito Y., Higashiyama H., Kanegane H., Futatani T., et al. Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations. Clin Immunol 125 (2007) 237-246
51. Bindl L., Torgerson T., Perroni L., Youssef N., Ochs H.D., Goulet O., et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 147 (2005) 256-259
52. Yong PL, Russo P, Sullivan KE. Use of Sirolimus in IPEX and IPEX-Like Children. J Clin Immunol. 2008 May 15. [Epub ahead of print]
53. Zhan H., Sinclair J., Adams S., Cale C.M., Murch S., Perroni L., et al. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Pediatrics 121 (2008) e998-e1002
54. Baud O., Goulet O., Canioni D., LeDeist F., Radford I., and Riev D. Treatment of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 344 (2001) 1758-1762
55. Rao A., Kamani N., Filipovich A., Lee S.M., Davies S.M., Dalal J., et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 109 (2007) 383-385
56. Lucas K.G., Ungar D., Comito M., Bayerl M., and Groh B. Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome. Bone Marrow Transplant 39 (2007) 55-56
57. Lucas K.G., Ungar D., Comito M., and Groh B. Epstein Barr virus induced lymphoma in a child with IPEX syndrome. Pediatr Blood Cancer 50 (2008) 1056-1057
58. Sharfe N, Dadi HK, Shahar M, Roifman CM. Proc Natl Acad Sci USA 1997; 94: 3168-71
59. Torgerson T.R. Regulatory T cells in human autoimmune diseases. Springer Semin Immun 28 (2006) 63-76
60. Roifman C.M. Human IL-2 receptor alpha chain deficiency. Pediatr Res 48 (2000) 6-11
61. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., and Verbsky J.W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119 (2007) 482-487